Cell-derived extracellular vesicles as a platform to identify low-invasive disease biomarkers
- 6 May 2015
- journal article
- review article
- Published by Taylor & Francis Ltd in Expert Review of Molecular Diagnostics
- Vol. 15 (7), 907-923
- https://doi.org/10.1586/14737159.2015.1043272
Abstract
Biomarkers are of great importance for prediction, diagnosis and monitoring the progression and therapeutic success of a disease. Whole body fluids, such as blood or urine, constitute the main desired biological source to identify these markers, mostly due to the minimally invasive procedures used to collect them. An additional benefit of studying these biological fluids that has been demonstrated by many different groups is that they contain cell-released extracellular vesicles, carrying a cargo of lipids, proteins and nucleic acids that reflects cell/tissue origin and, remarkably, cellular status. In this review, the information obtained from the characterization of this body fluid compartment in human samples is discussed in the context of its usefulness as diagnostic resource for several pathologies, including cancer, inflammatory, vascular and metabolic diseases. The review shows the great variety of methods used for this purpose as well as the different types of molecules that could serve as specific or common disease markers.Keywords
This publication has 86 references indexed in Scilit:
- Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking AnalysisNanomedicine: Nanotechnology, Biology and Medicine, 2011
- Quantitative Nanostructural and Single-Molecule Force Spectroscopy Biomolecular Analysis of Human-Saliva-Derived ExosomesLangmuir, 2011
- A filtration-based protocol to isolate human Plasma Membrane-derived Vesicles and exosomes from blood plasmaJournal of Immunological Methods, 2011
- Paracrine induction of endothelium by tumor exosomesLaboratory Investigation, 2009
- Platelet Microparticles: A Potential Predictive Factor of Survival in Hormone-Refractory Prostate Cancer Patients Treated with Docetaxel-Based ChemotherapyEuropean Urology, 2009
- Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancerBritish Journal of Cancer, 2009
- Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkersNature, 2008
- High expression of TROP2 correlates with poor prognosis in pancreatic cancerBritish Journal of Cancer, 2008
- MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer (Retracted article. See vol. 175, pg. 192, 2023)Gynecologic Oncology, 2008
- Exosomal Fetuin-A identified by proteomics: A novel urinary biomarker for detecting acute kidney injuryKidney International, 2006